title: Laser prostatectomy or TUIP for BPH?
abstract: Management of benign prostatic hypertrophy has been and continues to be a major focus of urologic care. Every year, some 300,000 transurethral resections are performed annually in the United States. In this Point and Counterpoint, Drs. Madsen, Bruskewitz, and Kabalin review the relative merits of transurethral incision and laser prostatectomy, two newer treatments for BPH.
authors.affiliation: Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: K R
authors.initials: KR
authors.lastname: Loughlin
mesh_terms: D004564:Electrocoagulation / Q000009:adverse effects / Q000191:economics; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects / Q000191:economics; D008297:Male; D011468:Prostatectomy / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000601:surgery*; D013673:Technology Assessment, Biomedical; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology / Q000601:surgery